Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase III trial to compare the effectiveness of methotrexate with that of
dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in
chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. It is not yet known whether methotrexate is more effective than dactinomycin in treating
patients with gestational trophoblastic neoplasia.
Phase:
Phase 3
Details
Lead Sponsor:
Gynecologic Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI)